Clinical Trials Directory

Trials / Completed

CompletedNCT02852980

Estimate Rate of the Women Who Have Gestational Diabetes

Retrospective Study to Estimate Screening of the Type 2 Diabetes of Women Who Had Childbirth in the Hospital Center Rene Dubos and Having Gestational Diabetes

Status
Completed
Phase
Study type
Observational
Enrollment
384 (actual)
Sponsor
Hôpital NOVO · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Retrospective study to estimate screening of the type 2 diabetes of women who had childbirth in the Hospital center Rene Dubos and having gestational diabetes.

Detailed description

It is recognized that pregnant women who had gestational diabetes (DG) multiplied by 7 subsequent risk of developing type 2 diabetes and this during 25 years. There is at present no formal recommendation of the High Authority for Health (HAS) as an organization of a long term screening for those women. However the recommendations of CNGOF (French Council of Gynaecologists and Obstetricians) and SFD (French society of diabetes) recommend screening for type 2 diabetes after a gestational diabetes in the postnatal consultation. But today how many women views due to a gestational diabetes have realized their screening? It is likely that the rate of occurrence of type 2 diabetes after gestational diabetes is underestimated today. Otherwise it is possible that the occurrence of type 2 diabetes is associated with some risk factors such as high BMI, insulin therapy during pregnancy. Another interrogation is the role of the doctor to reduce the number of women who do not realize their screening at 3 months postpartum. Better awareness of the importance of long term monitoring would reduce the proportion of women who do not realize their screening.

Conditions

Interventions

TypeNameDescription
OTHERgestational diabetes womenNo intervention.

Timeline

Start date
2015-07-01
Primary completion
2017-01-01
Completion
2017-01-01
First posted
2016-08-02
Last updated
2019-07-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02852980. Inclusion in this directory is not an endorsement.